Parkinson's
The company's FDA-cleared wearable uses personalized nerve stimulation to treat essential tremor and Parkinson's disease.
The study claims to be the first in the world to combine AI and optogenetics in Parkinson’s diagnosis and treatment.
It can also predict the onset of Parkinson's motor symptoms.
The technology was co-created by researchers at MIT Media Lab and Massachusetts General Hospital Sports Science Lab.
The platform, called Fox Insight Data Exploration Network, is set to combine patient surveys with genetic information for Parkinson's research.